110 related articles for article (PubMed ID: 11881729)
1. Immunohistochemical analysis of cyclooxygenase (COX)-2 expression in pancreatic endocrine tumors: association with tumor progression and proliferation.
Ohike N; Morohoshi T
Pathol Int; 2001 Oct; 51(10):770-7. PubMed ID: 11881729
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and clinicopathological correlation of the metastasis-associated gene 1 (MTA1) expression in benign and malignant pancreatic endocrine tumors.
Hofer MD; Chang MC; Hirko KA; Rubin MA; Nosé V
Mod Pathol; 2009 Jul; 22(7):933-9. PubMed ID: 19377441
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas.
Okami J; Nakamori S; Yamamoto H; Sakon M; Tsujie M; Hayashi N; Nagano H; Dono K; Umeshita K; Ishikawa O; Ohigashi H; Monden M
J Exp Clin Cancer Res; 2002 Dec; 21(4):569-76. PubMed ID: 12636104
[TBL] [Abstract][Full Text] [Related]
4. Pathological assessment of pancreatic endocrine tumors for metastatic potential and clinical prognosis.
Ohike N; Morohoshi T
Endocr Pathol; 2005; 16(1):33-40. PubMed ID: 16000844
[TBL] [Abstract][Full Text] [Related]
5. Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters.
Merati K; said Siadaty M; Andea A; Sarkar F; Ben-Josef E; Mohammad R; Philip P; Shields AF; Vaitkevicius V; Grignon DJ; Adsay NV
Am J Clin Oncol; 2001 Oct; 24(5):447-52. PubMed ID: 11586094
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumors.
Aoki T; Nagakawa Y; Tsuchida A; Kasuya K; Kitamura K; Inoue K; Ozawa T; Koyanagi Y; Itoi T
Oncol Rep; 2002; 9(4):761-5. PubMed ID: 12066205
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas.
Niijima M; Yamaguchi T; Ishihara T; Hara T; Kato K; Kondo F; Saisho H
Cancer; 2002 Mar; 94(5):1565-73. PubMed ID: 11920515
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 (COX-2) expression by immunohistochemistry in glioblastoma multiforme.
Prayson RA; Castilla EA; Vogelbaum MA; Barnett GH
Ann Diagn Pathol; 2002 Jun; 6(3):148-53. PubMed ID: 12089724
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.
Miyata Y; Koga S; Kanda S; Nishikido M; Hayashi T; Kanetake H
Clin Cancer Res; 2003 May; 9(5):1741-9. PubMed ID: 12738729
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis.
Aoki T; Tsukinoki K; Karakida K; Ota Y; Otsuru M; Kaneko A
Oral Oncol; 2004 Oct; 40(9):954-9. PubMed ID: 15380175
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 1999 Aug; 5(8):2018-24. PubMed ID: 10473081
[TBL] [Abstract][Full Text] [Related]
12. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA
Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas].
Wang HX; Chen QK
Ai Zheng; 2003 Jun; 22(6):649-52. PubMed ID: 12948419
[TBL] [Abstract][Full Text] [Related]
14. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
Long KB; Srivastava A; Hirsch MS; Hornick JL
Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
[TBL] [Abstract][Full Text] [Related]
15. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density.
Kasper HU; Wolf H; Drebber U; Wolf HK; Kern MA
World J Gastroenterol; 2004 Jul; 10(13):1918-22. PubMed ID: 15222037
[TBL] [Abstract][Full Text] [Related]
16. Low nuclear proliferative activity is associated with nonmetastatic islet cell tumors.
Jorda M; Ghorab Z; Fernandez G; Nassiri M; Hanly A; Nadji M
Arch Pathol Lab Med; 2003 Feb; 127(2):196-9. PubMed ID: 12562234
[TBL] [Abstract][Full Text] [Related]
17. Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma.
Li HL; Sun BZ; Ma FC
World J Gastroenterol; 2004 Jul; 10(13):1862-6. PubMed ID: 15222024
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors.
Kokawa A; Kondo H; Gotoda T; Ono H; Saito D; Nakadaira S; Kosuge T; Yoshida S
Cancer; 2001 Jan; 91(2):333-8. PubMed ID: 11180079
[TBL] [Abstract][Full Text] [Related]
19. Multihormonality and entrapment of islets in pancreatic endocrine tumors.
Kapran Y; Bauersfeld J; Anlauf M; Sipos B; Klöppel G
Virchows Arch; 2006 Apr; 448(4):394-8. PubMed ID: 16418841
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in pancreatic endocrine tumors.
Srivastava A; Alexander J; Lomakin I; Dayal Y
Hum Pathol; 2001 Nov; 32(11):1184-9. PubMed ID: 11727256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]